Discovery of SHP2 Inhibitor GDC-1971 (RLY-1971) Containing a Pyrazolopyrazine Core

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Synfacts 2024; 20(01): 0092
DOI: 10.1055/s-0043-1763634

Innovative Drug Discovery and Development

Contributor(s):

Antonia F. Stepan (Roche)

,

Seong Heon Kim (Hyundai Pharm)

SHP2 inhibitor - GDC-1971 - allosteric inhibitor - solid tumors - clinical candidate - pyrazolopyrazine

Article published online:
08 December 2023

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany